On Tuesday, May 5, 2026, the Stuart & Molly Sloan Precision Oncology Institute is hosting a symposium to explore new approaches to traditionally undruggable targets. This symposium will bring together thought leaders and discuss the latest breakthroughs, challenges, and future directions in turning previously elusive disease drivers into viable therapeutic opportunities for cancer and other diseases. Following talks, all attendees are invited to meet the speakers and enjoy a selection of food and beverages at a reception from 4:00 - 5:00 pm in the Sze Suites.
The Drugging the Undruggable Symposium is co-hosted by Behnam Nabet, PhD, Assistant Professor, Human Biology Division.
For schedule and speaker information see our agenda. Registration is open. All are welcomed and invited to attend. We hope you'll join us!
1100 Fairview Ave N, Seattle, WA 98109